Foetal and neonatal outcomes in an era of active management of intrahepatic cholestasis of pregnancy

Authors

DOI:

https://doi.org/10.18203/2320-1770.ijrcog20230123

Keywords:

Antenatal care, Intrahepatic cholestasis of pregnancy, Obstetric cholestasis

Abstract

Background: Intrahepatic cholestasis of pregnancy is one kind of hepatic disorder which is unique to pregnancy. It is associated with many adverse pregnancy outcomes if not intervened at the right time. It requires adequate clinical and biochemical correlation during management.

Methods: A prospective observational study was conducted in a tertiary care hospital among 1397 patients who underwent delivery during the study period from 01 July 2021 to 30 Jun 2022. Among the study population, those suspected to be having IHCP were subjected to laboratory tests and confirmed cases were further analysed for incidence and pregnancy outcomes in form of several maternal and fetal factors by appropriate statistical test using IBM SPSS version 20.0

Results: During the study period a total of 1397 patients underwent delivery out of which 174 showed clinical signs suggestive of IHCP. On subjecting these 174 suspected cases to further testing 53 patients were diagnosed with IHCP. The incidence of IHCP was 3.7% of which 28.30% (16/53) were primigravida. There were 22.64% (12/53) IVF pregnancies, 11.3% (6/53) were twin pregnancies. Total 28.30% cases (15/53) of IHCP presented with preterm labour. Of the total, there was 7.5% (4 /53) with meconium-stained liquor. Total 54.71% (29/53) cases underwent normal vaginal delivery, one forceps and one VBAC delivery, 45.28% (24/53) cases were underwent LSCS delivery and of this 70.8% (17/24) were emergency caesarean and 29.2% (7/24) were elective caesarean deliveries, 75% (18/24) were primary caesarean delivery. There were 25.4% (15/59) NICU admissions among new born of cases and 28.8% (17/59) were low birth weight babies. 25.4% (15/59) of neonates were seen to have APGAR score of less than 7 at 5 minute There was no stillbirth noted in diagnosed case of IHCP.

Conclusions: IHCP causes significant maternal and neonatal morbidity and is major contributor of preterm delivery, caesarean delivery, meconium-stained liquor and NICU admission.

References

Medda SSS, Palo U. A study of the outcome of pregnancy complicated by obstetric cholestasis. Int J Reprod Contracept Obstet Gynecol. 2018;7:996-1001.

Geenes V, Williamson C, Chappell LC. Intrahepatic cholestasis of pregnancy. Obstet Gynaecol. 2016; 18(4):273-81.

Kant AGS, Gupta U, Razdan A, Amle D. Maternal and perinatal outcome in cholestasis of pregnancy: a study in tertiary care hospital in North India. Int J Reprod Contracept Obstet Gynecol. 2018;7:5066-70.

Ge X, Xu YQ, Huang SH, Huang K, Mao LJ, Pan WJ, et al. Intrahepatic cholestasis of pregnancy and fetal outcomes: a prospective birth cohort study. Zhonghua Liu Xing Bing Xue Za Zhi. 2016;37(2):187-91.

Türkmen GG, Timur H, Yilmaz Z, Kirbas A, Daglar K, Tokmak A, et al. Effect of intrahepatic cholestasis of pregnancy on maternal serum screening tests. J Neonatal Perinatal Med. 2016;9(4):411-5.

Garcia-Flores J, Cañamares M, Cruceyra M, Garicano A, Espada M, Lopez A, et al. Clinical value of maternal bile Acid quantification in intrahepatic cholestasis of pregnancy as an adverse perinatal outcome predictor. Gynecol Obstet Invest. 2015;79(4):222-8.

Brouwers L, Koster MPH, Page-Christiaens GCML, Kemperman H, Boon J, Evers IM, et al. Intrahepatic cholestasis of pregnancy: maternal and fetal outcomes associated with elevated bile acid levels. Am J Obstet Gynecol. 2015;212:e1-7.

Wikstrom Shemer EA, Thorsell M, Marschall HU, Kaijser M. Risks of emergency cesarean section and fetal asphyxia after induction of labor in intrahepatic cholestasis of pregnancy: a hospital-based retrospective cohort study. Sexual and reproductive healthcare: Official J Swedish Asso Midwives. 2013; 4(1):17-22.

Harris M. SMFM recommendations: intrahepatic cholestasis of pregnancy. Available at: https://www.obgproject.com/2020/12/26/smfm-recommendations-intrahepatic-cholestasis-of-pregnancy/. Accessed on 20 November 2021.

Bacq Y, Sentilhes L, Reyes HB, Glantz A, Kondrackiene J, Binder T, et al. Efficacy of ursodeoxycholic acid in treating intrahepatic cholestasis of pregnancy: a meta-analysis. Gastroenterol. 2012;143(6):1492-501.

Al Shobaili HA, Hamed HO, Al Robaee A, Alzolibani AA, Amin AF, Ahmad SR. Obstetrical and fetal outcomes of a new management strategy in patients with intra-hepatic cholestasis of pregnancy. Arch Gynecol Obstet. 2011;283(6):1219-25.

Padmaja M, Bhaskar P, Kumar GJ, Seetha R, Mahasweta C. A study of obstetric cholestasis. J Obstet Gynaecol India. 2010;60(3):225-31.

Dang A, Agarwal N, Bathla S, Sharma N, Balani S. Prevalence of liver disease in pregnancy and its outcome with emphasis on obstetric cholestasis: An Indian scenario. J Obstet Gynaecol India. 2010;60(5): 413-8.

Kondrackiene J, Kupcinskas L. Intrahepatic cholestasis of pregnancy-current achievements and unsolved problems. World J Gastroenterol. 2008;14(38):5781-8.

Glantz A, Marschall HU, Mattsson LA. Intrahepatic cholestasis of pregnancy: Relationships between bile acid levels and fetal complication rates. Hepatol. 2004; 40(2):467-74.

Palma J, Reyes H, Ribalta J, Hernández I, Sandoval L, Almuna R, et al. Ursodeoxycholic acid in the treatment of cholestasis of pregnancy: a randomized, double-blind study controlled with placebo. J Hepatol. 1997; 27(6):1022-8-12.

Davies MH, da Silva RC, Jones SR, Weaver JB, Elias E. Fetal mortality associated with cholestasis of pregnancy and the potential benefit of therapy with ursodeoxycholic acid. Gut. 1995;37(4):580-4.

Mahajan NAA, Lone MI. Outcome of pregnancy complicated by obstetric cholestasis: a prospective study. IJSS. 2017;5(3):271-4.

Alsulyman OM, Ouzounian JG, Ames-Castro M, Goodwin TM. Intrahepatic cholestasis of pregnancy: perinatal outcome associated with expectant management. Am J Obstet Gynecol. 1996;175(4):957-60.

Downloads

Published

2023-01-25

Issue

Section

Original Research Articles